The first two authors contributed equally to this study In patients with obesity and diabetes mellitus, abnormal production of inflammatory factors may result in cardiovascular dysfunction. In the current study, we tested the impact of CDld-mediated innate immune responses on the expression and activation of NFKB in the hearts of adipose diabetic (db/db) mice. Splenocytes from adult db/db and CDld-knockout mice of both genders and their wildtype, C57BL/6 and Balb/C counterparts were examined for tumor necrosis factor (TNF)-a and TNF-a receptor type 1. The percentage of natural killer T (NKT) cells in CD3+ T cells was compared with that in nondiabetic control mice. Despite the absence of inflammatory infiltrates, the hearts of db/db mice showed alterations in TNF-a receptor-I and NFKB activity, including increased expression of both the NFKB p52 and p65 subunits. In the hearts of CDld-knockout mice, p52 expression was reduced, while p65 expression remained largely unchanged. On echocardiography, the ratio of E to A transmitral flow velocities (an indicator of diastolic function) was significantly decreased in db/db mice after they swam for 30 minutes. These results provide evidence for CDld-mediated NFKB activation and diastolic dysfunction in the hearts of db/db mice. Therefore, CDld-associated abnormalities of innate immune responses and TNF-a production in splenic tissue may contribute to NFKB activation and cardiac dysfunction in type 2 diabetes.
The concept that type 2 diabetes mellitus is a chronic inflammatory disease is widely accepted, owing to the growing body of evidence indicating that chronic, low-grade inflammation serves as a common denominator of diabetes, linking obesity, insulin resistance, and cardiovascular complications (1) . By increasing the circulating levels of proinflammatory cytokines such as tumor necrosis factor (TNF)-a, monocyte chemoattractant protein-I, and interleukin-l~, chronic hyperglycemia creates a proinflammatory milieu that leads to insulinresistance and cardiovascular inflammatory complications, such as atherosclerosis, ischemic myocardial disease, heart failure, and dilated cardiomyopathy (2) .
Researchers are increasingly recognizing that activation of the innate immune system plays a role in the development and progression of insulin resistance by inducing chronic, low-grade inflammation (3) . Although the innate immune system provides the first line of defense against microbial pathogens, it also plays an important role in amplifying the inflammatory response, which does not depend on antigenic stimulation. Both infection-induced and sterile inflammation can lead to chronic inflammation, a key etiological condition in the development of insulin resistance. However, the molecular and cellular basis of innate immune regulation in the progression of diabetes-associated cardiovascular diseases has not been fully elucidated.
The spleen contains a variety of innate immune cells, predominantly natural killer (NK) and invariant natural killer T (NKT) cells (4) . The proportion of NKT cells is considerably higher in splenic mononuclear cells than in blood and other lymphoid organs, including the thymus (5) . NKT cells are a heterogeneous subset of lymphocytes that express both NK and T cell surface markers (6) . In mice, classic (type I) NKT cells express an invariant T cell receptor containing a Va14-Ja18 chain, whereas nonclassic (type II) NKT cells express diverse T cell receptors (6) . NKT cells recognize a glycolipid antigen presented by CDld, a major histocompatibility complex molecule expressed in antigen-presenting cells such as dendritic cells and macrophages (6) . Because CDld is essential for the development of NKT cells (6) , genetic disruption of this molecule depletes both type I and type II NKT cells in the whole body (7) .
There is a growing consensus that glucose-and diabetes-induced activation of nuclear factor-KB (NFKB) contributes to the proinflammatory diabetic milieu, including heart tissue inflammation (8) . The NFKB family of transcription factors is controlled by 2 distinct mechanisms of activation known as the canonical (classic) pathway, which determines the release of p50/p65 dimers to the nucleus, and the noncanonical pathway, which causes pi 00 processing and nuclear translocation of RelB/p52 (9) . The canonical pathway plays an important role in the host's innate immune response by inducing expression of numerous proinflammatory cytokines, chemokines, adhesion molecules, inducible enzymes, and proangiogenic growth factors, as well as by inhibiting apoptosis (10) . The more recently identified noncanonical pathway plays an important role in the adaptive immune response, including secondary lymphoid organogenesis and lymphocyte maturation (11) .
We hypothesized that the CDld-mediated splenic inflammatory response activates the innate immune pathway of cardiac muscle cells in a paracrine manner, by secreting cytokines such as TNF -a and consequently activating the canonical NFKB pathway. We sought to determine whether direct activation of innate immune sensors by CDldrestricted NKT cells in the spleen is associated with expression and activation of the NFKB signaling pathway in the hearts of obese diabetic (db/db) mice with insulin resistance. In this report, we describe the association of splenic inflammatory responses with the expression of TNF-a receptor type 1 and strong activation of NFKB, significant alteration of canonical RelNp65, and to a lesser extent, expression of the noncanonical RelB/p52 subunit in the hearts of db/db mice. Our observations suggest that the abnormal immune responses and TNF-a production in spleen tissue plays a role in NFKB activation, which is crucial for the development and progression of cardiovascular dysfunction in diabetes.
MATERIALS AND METHODS

Animals and their care
The study population comprised wild-type C57BL/6 mice (body weight: 22±4 g; 3 males and 3 females), wildtype Balb/C mice (body weight: 21±4 g; 3 males and 3 females), COld-knockout mice (body weight: 25±5 g; 3 males and 3 females), and Lepr" (db/db) mice on a C57BL/6 background (homozygotes for a mutation in the leptin receptor gene, leading to the loss of functional leptin receptors) (12) (body weight: 76±5 g; 3 males and 3 females). All mice were 12-month-old adults obtained from The Jackson Laboratories (Bar Harbor, Maine, USA).
TablesI and II showthe physiologicaland biochemical characteristics of db/db, C57BL/6, CDld-knockout, and Balb/C mice. Db/db mice on a C57BL/6J background develop hyperphagia, obesity, and insulin resistance,with severe depletion of the insulin-producing beta-cells of the pancreatic islets (12) . The diabetic phenotype of these mice, however,is less severe than that of db/db mice on a KsJ background (13) . The latter are more severely insulin resistant but less hyperglycemic than db/db mice on a C57BL/6J background (13) . Moreover, db/db mice on a C57BL/6J background develop higher plasma fatty acid levels than do db/db mice on a KsJ background.
All mice were specific-pathogen free and kept in a temperature-controlled environment in a ventilated rack with a 12:12-hour lightdark cycle. Food and water were given ad libitum. All procedures were approved by the Institutional Ethics Committee (University of Texas Health Science Center at Houston) for animal research. The investigations conformed to the Principles of Laboratory Animal Care formulated by the National Society for Medical Research and the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (USA).
Materials
All chemicals were purchased from Sigma-Aldrich (St. Louis, Missouri, USA) unless otherwise specified. Type-I collagenase was obtained from Worthington Biochemical Corporation (Lakewood, New Jersey, USA).
Blood collection and biochemical assays
Blood was drawn via a cardiac puncture, collected into nonheparinized tubes, allowed to clot at room temperature for 1 hour, and centrifuged for 20 minutes at 2,000 x g. The serum was removed and stored at -20 DC until assays were performed. Levels of glucose, triglyceride, and the total, high-density lipoprotein (HDL], low-density lipoprotein (LDL), and very-low-density lipoprotein (VLDL) cholesterol were measured by standard clinical chemistry laboratory methods (Equine Laboratories, Houston, Texas, USA).
Flow cytometry
After being anesthetized with an intraperitoneal injection of 65 mg/kg ketamine and 13 mg/mL xylazine in sterile normal saline, the wild-type C57BL/6 and db/db/ C57BL/6 mice were euthanized. The spleens of male db/ db mice and age-and sex-matched C57BL/6J control mice were removed, mashed by the plunger of the syringe, and passed through a 70 IlM cell strainer. After red-blood-cell removal, spleen cells were plated in RPMI 1640 culture medium supplemented with 20% fetal bovine serum (Gibco, Invitrogen; Life Technologies, Grand Island, New York, USA), penicillin (100 U/mL), and streptomycin sulfate (100 mg/mL). For flow cytometry analysis and cell sorting, spleen cells (1x 10 6 ) were incubated for 30 minutes at 4DC with 10 ul, ofphycoerythrin-conjugated mouse anti-CDld antibody (Santa Cruz Biotechnology, Santa Cruz, California, USA). An antibody specific for the FcyRIII/II receptor (BD Biosciences, San Jose, California, USA) was used to inhibit nonspecific staining. Cells were analyzed with a BS LSRII flow cytometer (BD Biosciences). For each sample, 30,000 events were acquired and analyzed with CellQuest software (BD Biosciences). Subsequently, CDld+ splenocytes were sorted from CDld-splenocytes with a fluorescence-activated cell sorter (BS LSRII flow cytometer sorter; BD Biosciences) and used for further analyses.
RNA Analysis by Quantitative Real-time Polymerase Chain Reaction (qRT-PCR)
Total RNA was isolated with a Qiagen RNA isolation kit. First-strand eDNA synthesis was performed with an iScript™ eDNA Synthesis Kit (Bio-Rad Laboratories, Hercules, California, USA) according to the manufacturer's protocol. The following qRT-PCR primers, designed with Oligof'erfect" Designer software (Invitrogen), were used: mCDl(5'-AAGCTGGTCCCGCACAGA-3', 3' -GCTGATGGTGGCTGAGTCATT-5'), TNF-a (5' -TCGTAGCAAACCACCAAGTG-3', 3' -AGATAGCAAATCGGCTGACG-5'), TNF-a receptor! (5' -CCATCTTCGGTCCTAGTAACTG-3', 3'CAGGTTCATCTTGGAAAGCAC-5 '), TNFa receptor2
(5' -GATGCCAAGGTGCCTCATG-3', 3' GAGCTGCTACAG ACGTTCACG-5'), brain natriuretic peptide (BNP) (5' -CTGAAGGTGCTGTCCCAGAT-3', 3' -CCTTGGTCCTTCAAGAGCTG-3 '). All qRT-PCR reactions were performed in triplicate by using a MyiQTM Single-Color Real-Time PCR detection system (Bio-Rad). A melting curve was generated at the end of every run to ensure product uniformity. Relative values were obtained by normalizing CT values of the tested genes in comparison with CT values of the housekeeping gene RNA GAPDH, using the~CT method.
Tissuepreparation and histological analyses
After anesthesia was induced, the hearts from wildtype C57BL/6 and db/db/C57BL/6 mice were perfusionfixed with 4% paraformaldehyde and 5% sucrose in phosphate-buffered saline (PBS) for 10 min, then removed from the chest, embedded in optimal-cutting-temperature (OCT) compound, frozen on dry ice, and stored at -70 DC until sectioning. Serial 7-llm-thick sections were obtained by using a sliding cryotome. For immunofluorescence staining, these sections were permeabilized, blocked for 30 min in PBS containing 1% bovine serum albumin, and incubated for 1 h at 4 DC with primary antibody against rabbit sarcomeric n-actinin cross-reacting with mouse. After being washed with PBS, the heart sections were incubated with fluorescein isothiocyanate-conjugated antirabbit secondary antibody. Nonimmune IgG was used as the isotype control (Becton, Dickinson and Co., Franklin Lakes, New Jersey, USA). The slides were washed, mounted, and viewed through a fluorescence microscope.
Heart sections were also prepared with hematoxylin and eosin (H&E) stain for structural analysis by light microscopy, with Sirius red stain to assess the presence and extent of fibrosis and with Oil Red a stain to identify intramyocardial lipid deposition. Images were obtained with a digital camera and analyzed by using the Metamorph Image System (Molecular Devices Corp., Downingtown, Pennsylvania, USA).
Electrophoretic Mobility Shift Assays (EMSAs)
Nuclear proteins from wild-type C57BL/6 and db/dbl C57BL/6 mice and from wild-type Balb/C and CDldknockout mice were extracted from snap-frozen hearts as previously described (14) . Briefly, tissues were harvested and homogenized with an Ultra-Turrax T25-tissue homogenizer (Janke and Kunkel) in a low-salt solution (0.6% Nonidet P-40; 150mMNaCl; 10 mM HEPES, pH 7.9; 1 mMEDTA; 0.5 mM phenylmethylsulfonyl fluoride), and centrifuged for 30 seconds at 2,000 rpm. The supernatant was incubated on ice for 5 minutes and then centrifuged at 5,000 rpm for 5 min. The nuclei were resuspended in a high-salt solution (25% glycerol; 20 mM HEPES, pH 7.9; 420 mM NaCl; 1.2 mM MgC12; 0.2 mM EDTA; 0.5 mM dithiothreitol; 0.5 mM phenylmethylsulfonyl fluoride; 2 mM benzarnidine; 5 g/mL each aprotinin, leupeptin, and pepstatin). Protein concentrations were determined by Bio-Rad Laboratories Protein Assay. Double-stranded NFJeB oligonucleotides (5'-AGT TGA GGG GAC TIT CCC AGG C-3' and 5'-CCT GGG AAA GTC CCC TCA ACT-3') (promega, Madison, Wisconsin, USA) were labeled with [y_32P]ATP. Binding reactions containing 10 ug of crude nuclear extract were performed by using an EMSA core system (Promega) according to the manufacturer's protocol. For supershift assays, I~L of goat monoclonal anti-p65 antibody (Santa Cruz Biotechnology) was added into the reaction tube, with a final volume of I0~L, containing I0 ug of crude nuclear extract.
Immunoblottingfor p65 andpI 00/52 NF-KB subunits
Total proteins from wild-type C57BL/6 and db/dbl C57BL/6 mice and from wild-type Balb/C and CDldknockout mice were extracted from heart, spleen, lymph node, and heparinized peripheral blood samples snapfrozen in liquid nitrogen. At 4°C, the frozen samples were ground into a fine powder and homogenized by a polytron in cold lysis buffer (50 mM HEPES, pH 7.5; 150 mM NaCl; 10 mM NaPP; 2 mM Na 3V04 ; I mM MgCI 2; I mM CaCI 2; 10 mM NaF; 2 mM EDTA; 2 mM PMSF; 5 ug/ml, leupeptin; 1% NP-40; 10% glycerol). They were then centrifuged at 25,000 rpm at 4°C for 30 min to remove insoluble material, and the supernatant was used as a sample. An aliquot of the nuclear extracts used for EMSA and cytosolic or total extracts were loaded on 5-10% SDS-polyacrylamide for gel electrophoresis under reducing conditions (14) and were electroblotted onto polyvinylidene fluoride membranes (Immobilon-P+; Millipore, Bedford, Massachusetts, USA). Each membrane was blocked in 3% goat serum for I h and incubated overnight at 4°C with the following primary antibodies: I) polyclonal anti-rabbit p65 (Santa Cruz Biotechnology); 2) polyclonal anti-rabbit plO0/52 (Cell Signaling Technology, Inc., Danvers, Massachusetts, USA); 2) anti-B-actin (Sigma-Aldrich); 3) anti-lamin B (Santa Cruz Biotechnology). The blots were developed using a SuperSignal West Pico Chemiluminescent Substrate kit (Pierce Biotechnology, Inc., Rockford, Illinois, USA). The intensity of each immunoreactive protein band was measured by densitometry.
Swimming exercise and echocardiography
Sex-and age-matched db/db and wild-type (C57) mice were subjected to a 30-minute swimming session followed by 5 minutes ofrest. Constant monitoring ensured the safety of the mice and prevented them from floating or holding their breath under water. Before swimming (baseline) and after completion of the swimming-rest program, the mice underwent transthoracic echocardiography. They were anesthetized with ketamine (100 mg/Kg) and placed in the supine position. Two-dimensional and M-mode echocardiographic images were recorded and analyzed by a Vevo 770 echocardiograph equipped with a 40-MHz ultrasonic linear probe (Visual Sonics, Toronto, Canada). Two-dimensional transverse left ventricular (LV) imaging was used to position the probe just distal to the mitral valve leaflets, and M-mode images were then captured in the short and long axes. Three loops of M-mode data were captured from each animal and stored on digital disk until analysis. Each image loop provided 5 to 12 heart cycles; data were averaged from at least 5 cycles per loop. Left ventricular internal systolic (LVIDs) and diastolic (LVIDd) diameters were measured, as were diastolic anterior and posterior wall thickness, according to the American Society of Echocardiography's leadingedge technique. These parameters allowed LV fractional shortening (% FS), a measure of systolic function, to be determined by the equation: 
Statistical analysis
All results are presented as mean values ± standard deviation (SD). Two-group comparisons were performed by using Student's r-test for unpaired values. Multiplegroup comparisons were made by using analysis of variance (ANOVA). P values of less than 0.05 were considered significant. Statistical analyses were carried out with SPSS software, version 15.0 (SPSS, Inc., Chicago , Illinois , USA).
RESULTS
Obesity, lipid profiles, and CDld expression in db/ db mice As expected, 12-month-old db/db mice fed normal chow gained significantly in body weight, with marked elevation of blood lipids and glucose levels. At the same age, db/db mice were much heavier than nondiabetic C57 control mice (P<O .OI; Table   I ). These 2 groups also had a modest, but significant difference in heart weight and heart weight/body weight ratio (P<O.05) . The blood levels of glucose, total cholesterol, LDL and VLDL cholesterol, and triglycerides were significantly increased in the db/ db mice versus nondiabetic control mice (P<O.O I; P<O.OI; P<O.OI; P<O.05; or P<O.OI, respectively ; n=3 mice per each group; Table I ). Thus, compared to control C57 mice, db/db mice developed severe obesity, hyperlipidemia , and hyperglycemia.
Expression of CD Id in the spleens of C57BL/6J and db/db mice was analyzed by flow cytometry with phycoerythrin-conjugated anti-CD Id antibody. Higher numbers of spleen cells displayed CDld expression in db/db mice than in sex-and age-
..... 42.8±5.8% (n=3); P<O.05, db/db vs. C57BL/6 mice] ( Fig. 1 A, B) . Quantitative RT-PCR showed that CD1d mRNA expression increased in splenocytes from db/db mice compared with C57BL/6 control mice after normalization with GAPDH mRNA levels ( Fig. 1 C,D) . Thus, CDI expression is increased in the splenocytes of db/db mice.
Increased splenocytic TNF-o. and cardiac TNF-o. receptor-l mRNA expression in db/db mice TNF-a mRNA in the spleens ofC57BL/6J and db/ db mice was measured by using qRT-PCR. As shown in Fig. 2 A,B , a 6-fold increase in the levels ofTNF-a mRNA was seen in the spleen cells of db/db versus C57BL/6 mice. Conversely, expression of TNF-a receptor-l ( Fig. 2C ), but not receptor 2 mRNA (Fig.  2D) , was significantly increased in the db/db mouse hearts, corresponding to the elevation of TNF-a mRNA in the splenocytes ofdb/db mice. On qRT-PCR, expression ofTNF-a receptor-l was 4.9-fold higher in the hearts of db/db mice than those ofC57BL/6J mice (P<O.Ol db/db vs C57 mice) (Fig. 2C) .
Differential p65 subunit expression and activities in hearts ofdb/db and CDld-knockout mice
The nuclear transcription factor NFKB binds to the promoters that are critical for transcription of a variety of proinflammatory genes. We analyzed the expression and activities of NFKB in the hearts of db/db and C57 mice. Levels of the NFKB p65 subunit were determined by Western blot analysis in db/db and CDld-knockout mice and their wild-type counterparts (C57BL/6 and Balb/C, respectively). Stronger bands of p65 proteins were found in the cardiac nuclear extracts of db/db mice than of C57 control mice, especially in female animals (Fig.  3A) . Also, p65 was found in the hearts of CD1d-null and Balb/C mice (Fig. 3B ). However, the nuclear expression of the NFKB p65 subunit in the hearts of CD1d-knockout mice appeared to be lower than that of the wild-type controls (Fig. 3B) .
To determine the NFKB activities, we conducted a gel shift assay with 32p end-labeled NF-kB oligonucleotides, using the nuclear proteins isolated from snap-frozen hearts. NFKB binding actrvmes were much stronger in the nuclear extracts from ageand sex-matched hearts of db/db mice than from the wild-type controls (Fig. 3C) . The specificity of the NFKB-DNA protein complex formation was verified by competition with cold oligonucleotides and by addition of anti-p65 NFKB antibody, which super-shifted the bands of NFKB/DNA complexes (Fig. 3C, lanes 1,3,5, 7) . Antibody to p65/RelA was capable of super-shifting a portion of the protein binding to the nuclear DNA, indicating p65 subunit involvement in activation of NFKB in the db/db hearts. The binding activity with the radioactive oligonucleotide probe was abolished in the absence of protein extracts (Fig. 3C, lane 9) indicating the dependence on nuclear protein factor binding for the shifted radioactive bands.
CD1d association with NF-kB precursor expression andprocessing in hearts
The NFKB p65 subunit was highly detectable in cytosolic extracts from CDld-knockout mice (Fig. 3B) , indicating lack of cytosolic-nuclear redistribution of p65 and, therefore, lack of activation of canonical NFKB in the absence of CD 1d. When whole heart extracts were analyzed by immunoblotting for processing of the pi 00 precursor into the p52 active subunit, levels ofp52 in the hearts ofdb/db mice and nondiabetic C57BL/6 control mice reflected p65 expression and NF-kB binding activity, although to a lesser extent than in the other group of mice (Fig. 4A) . A marked reduction in RelB/p52 expression was observed in the hearts of CD 1dknockout mice versus Balb/C control mice (Fig. 4C ). The spleen (Fig. 4B ) and blood ( Fig. 5A ) showed marked expression of RelB/p52 in db/db mice compared with nondiabetic C57BL/6 control mice. However, in the spleen and blood of CD1d-knockout mice, no significant levels ofp52 were detected (Fig.  5B) , indicating lack of activation of noncanonical NF-KB in the absence ofCDld.
Cardiomyocyte lipid accumulation and global morphology ofdb/db hearts
Insulin resistance is frequently associated with lipid deposition in nonadipose tissue. The hearts of db/db mice showed large quantities of lipid accumulation within the ventricles, as visualized with Oil red a staining (Fig. 6A) , along with increased depots in the fat pads around the ventricles. Few lipid stains were found in the hearts of C57BL/6 mice (Fig. 6E ). Although lipid accumulation was seen in db/db mice, global morphology and cardiomyocyte structure remained largely unchanged. In db/db mice, no cardiac hypertrophy was apparent on H&E staining (Fig. 6B ), and no fibrosis was observed on sirius red staining (Fig. 6D ) as compared with C57BL/6 mice (Fig. 6F, H) . Immunofluorescence staining for a-sarcomeric actinin (a crucial Z-disc protein that cross-links sarcomeric actin) revealed that the heart tissue had sarcomeric integrity without microscopically detectable anomalies (Fig. 6C) ; the myocytes showed patterns of striated myofibrils similar to those of the control C57 mice (Fig. 6G) .
Changes in cardiac performance in db/db mice undergoing stress testing
M-mode measurements of LV dimensions and indexes of systolic heart function showed no significant difference between the db/db and nondiabetic control mice at baseline and after exercise (Table III; n=6) . On Doppler flow analysis, the ratio of E to A transmitral flow velocities (an indicator of diastolic function) was significantly decreased in db/db mice after exercise, indicating impaired LV relaxation (Fig. 7) . The exercise-induced increase in fractional shortening was not significantly different in db/db versus nondiabetic control mice (Table  ORO  H&E R. MADONNA ET AL. Ill). Of note, there was no difference in the effect of exercise on heart rate between db/db and nondiabetic control mice (Table Ill) , indicating a similar cardiac compensatory response to stress by adrenergic stimulation in the 2 groups. Expression of BNP rnRNA, a highly sensitive indicator of cardiac dysfunction in diabetic mice (15) and in humans (16) , was significantly higher in db/db mice [males, 1.58±O.7 pg/mL (n=4); females, 1.66±OA pg/mL (n=4)] versus nondiabetic control mice [males, O.73±O.3 pg/mL; females, O.97±OA pg/mL]. Thus, increased BNP mRNA expression appeared to change in parallel with alterations in cardiac diastolic function in db/db mice.
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DISCUSSION
An association between low-grade chronic inflammation and cardiovascular complications in insulin resistance and type 2 diabetes is increasingly being recognized (l). However, the molecular and cellular basis of immune dysregulation leading to low-grade chronic inflammation and cardiac malfunction in type 2 diabetes has not been fully elucidated. Our current study provides experimental evidence that a heightened innate immune response occurs through a CD 1d-mediated mechanism .
In the spleen, CD 1d-restricted, lipid-responding NKT cells result in a variety of immune reactions, including induction ofT helper-derived inflammatory cytokines (17) , suggesting that these cells have complex roles in immune dysregulation and inflammation. In this study, we hypothesized a link between systemic low-grade chronic inflammation and activation of selective elements of the innate immune system, such as CDld-restricted NKT cells in obese diabetic (db/db) mice. We demonstrated that spleen inflammatory responses characterized by activation of CDld-restricted NKT cells are associated with expression and activation of NF-KB in the hearts of adipose db/db mice. In our study, spleen tissues of db/db mice displayed high levels of CD1+ NKT cells, particularly in younger mice.
It is likely that activated CD1d-restricted NKT cells produce high levels of proinflammatory cytokines, such as TNFa and interleukin-l , which circulate to the heart and cause cardiac malfunction (Fig. 8 ). However, there is no direct evidence that CD1dassociated NKT cell activation contributes to cardiac .dysfunction. Miyazaki and colleagues recently reported that the population of NKT cells may decline in mice fed a high-fat diet (108). Therefore, high-fat feeding may have different biological effects on CDld-mediated NKT cell function than the endogenous hyperlipidemia developed in db/db mice.
CDld is known to playa key role in presenting 
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Obese diabetic (db/db) m ice with glyco-/ipid an tig ens (jJ TCR Glycolipid CD1d Fig. 8 . CDId-associated expression of NFKB and cardiac dysfunction in type 2 diabetes. In type 2 diabetes, TNF-a production in splenic tissue may contribute to NFKB activation and cardiac dysfunction. NKT: natural killer T; TNF: tumor necrosis factor; TNFR: tumor necrosis factor receptor; TCR: T-cell receptor.
glyco-lipid antigen molecules to certain T subsets, particularly NKT cells (19) . Conceivably, lipid accumulation in the organs or tissues of obese diabetic mice, including the heart, may facilitate the generation of denatured, chemically modified lipid molecules, which act as auto-antigens recognized by CDld-restricted NKT cells (20) . Therefore, because CD1d plays a key role in lipid antigen presentation, this molecule can facilitate innate immune responses involving NKT cells, thus participating in the inflammatory responses In obese db/db mice. Our observations suggest that spleen CDldrestricted NKT cells playa crucial role in activating inflammatory responses and NFKB signaling in the hearts of such mice. This activation is crucial for the development and progression of cardiovascular dysfunction in diabetes.
Another interesting finding in this study concerns CDld-dependent expression and activation of NF-kB in the myocardium. Our data clearly show that heart tissues of db/db mice express high levels of TNF-n receptor type 1 and NFKB, paralleled by lipid accumulation and diastolic dysfunction. Furthermore, the heart, spleen, and blood of CD1dknockout mice, which lack mature NKT cells systemically, display no activation ofthe p65 subunit and have markedly reduced RelB/p52 expression, indicating a compromised capacity for NFKBmediated inflammation in the absence of CD1d.
Recent studies have emphasized the existence of multiple facets of NFKB in the heart, suggesting that the timing, duration of activation, and cellular context may explain mechanistically differential outcomes of cardiac NFKB signaling (21) . Whereas NFKB is cardioprotective during acute hypoxia and reperfusion injury, prolonged activation of NFKB appears to promote heart failure by eliciting signals that trigger chronic inflammation through enhanced elaboration of cytokines -including TNF-n, interleukin-I, and interleukin-6 -leading to endoplasmic reticular stress and cell death (22) .
A novel finding of our study is dysregulation of the noncanonical NFKB activation pathway, with significant changes in expression of the plOO/p52 protein complex. Our finding that the cytosolic p52 subunit was increased in the hearts and peripheral blood of db/db versus nondiabetic mice indicates a marked processing of the pi 00 precursor into the p52 active subunit and supports activation of the noncanonical NFKB pathway in the presence of diabetes. Unlike canonical NFKB signaling, noncanonical NFKB signaling in the heart has not been widely studied (21) . In other cell systems, the major ligands of the noncanonical pathway include lymphotoxin-B, B-cell activating factor, and the CD40 ligand (23) . Activation of these respective receptors results in phosphorylation of plOO at Ser866 and Ser870 and subsequent processing, resulting in active p52 (24) . In previous studies, noncanonical NFKB activation has been observed in pig models of ischemia-reperfusion renal injury, possibly indicating a role for this signaling pathway in the development of nephropathy (25) . The significance of noncanonical NFKB activation in the hearts of our diabetic mice remains unclear and awaits further investigations.
Our observation that TNF-a and TNFa-receptor were increased in the hearts ofdiabetic mice indicates chronic activation of the innate immune response via prolonged activation of the NFKB pathway. The possibility that infiltrating neutrophils, monocytes, and macrophages also are responsible for cytokine production cannot be ruled out, but it appears unlikely given the low numbers of infiltrating macrophages or lymphocytes in the heart tissue.
In db/db mice, lipid accumulation in ventricular cardiac myocytes and increased depots in fat pads around the ventricles occurs with development of cardiac dysfunction before cardiomyopathy and fibrosis are microscopically detectable. Similar findings have been observed in leptin-deficient obese fa/fa rats (26) ..Although the physiological role of lipids in the db/db heart may be simply to store energy, excess lipid accumulation may contribute to oxidative stress and cardiac dysfunction through direct activation of NFKB and expression of inflammatory cytokines. Alternatively, lipid accumulation can affect the biomechanical function of the heart, eg, by affecting Ca 2 + -binding to the sarcolemmal membrane (27) or increasing chamber and myocardial stiffness. Study ofthe end-diastolic pressure-volume and stressstrain relationship in isolated hearts from both lean and obese rabbits and in a murine model of isolated cardiac steatosis at different end-diastolic volumes has shown markedly decreased diastolic compliance due to increased ventricular-chamber and myocardial stiffness (28, 29) . The stiffer ventricles per se impair cardiac function, as higher filling pressure is required to expand the ventricles and ensure adequate filling and contraction. The concurrent' increase in atrial pressures not only impairs venous return to the heart but also increases intramyocardial capillary pressures and cardiac wall edema, which evolves into fibrosis over time (30) .
In humans, obesity is independently associated with an increase in morbidity and mortality, resulting primarily from stroke, coronary artery disease, and congestive heart failure (31) . Interestingly, some obese patients with symptoms of systemic and pulmonary congestion have normal systolic function; however, diastolic function is often abnormal (32) , and 35% to 40% of patients with congestive heart failure may have diastolic dysfunction only (33) . Furthermore, diastolic dysfunction and pulmonary hypertension can be worse after exercise. In dogs given a high-fat diet for 4 weeks, the resulting weight gain led to a significant increase in left atrial pressure, both at rest and (more importantly) during exercise, and to a net decrease in exercise tolerance (34) . In addition, the hearts of obese rabbits exhibit mild systolic dysfunction, with reduced contractile responsiveness to isoproterenol (35) . In our study, echocardiography with Doppler flow analysis revealed pronounced changes in the cardiac diastolic function of db/db mice after exercise: specifically, the peak height of the A-wave increased, while the E/A ratio decreased, reflecting impaired LV relaxation during diastole. In the Otsuka Long Evans Tokushima Fatty (OLETF) rat model of type 2 diabetes, diastolic cardiac dysfunction develops in parallel with interstitial collagen accumulation (36) . In our study, however, we detected no gross differences in interstitial collagen deposition in the hearts of db/db mice. Furthermore, LV mass and relative wall thickness were unchanged, suggesting that diastolic dysfunction was not paralleled by cardiac hypertrophy in db/db mice but was solely imputed to lipid accumulation within and around the heart. Fractional shortening was similar to that observed in db/db mice at baseline. However, BNP mRNA expression was significantly increased in db/ db versus nondiabetic mice. These data suggest that marked lipid accumulation in db/db mouse hearts is associated with cardiac diastolic dysfunction (of the chamber rather than wall) without evidence of systolic dysfunction, at least up to 12 months of age. This finding agrees with the clinical observation that impairment of diastolic function precedes impairment of systolic function by decades in humans with diabetes (37) .
In conclusion, spleen inflammatory responses are associated with expression of TNF-a receptor type 1 and strong activation of NF-KB, significant alteration of canonical RelA/p65, and (to a lesser extent) expression of the noncanonical RelB/p52 subunit in the hearts of diabetic mice. These hearts also displayed a markedly increased lipid content, which may at least partially reflect activation of NFKB and induction of cardiac proinflammatory genes. Echocardiography with Doppler flow analysis and measurements of cardiac BNP expression revealed diastolic dysfunction with no signs of systolic dysfunction. Therefore, in obese db/db mice, abnormal immune responses and TNF-a production in spleen tissue, along with cardiomyocyte lipid accumulation, may play a role in NFKB activation in the heart, with consequent development and progression of diastolic cardiac dysfunction.
